EQ logo

Equillium (EQ)

Profile

Full Name

Equillium, Inc.

Ticker Symbol

EQ

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 12, 2018

Indexes

Not included

Website

http://www.equilliumbio.com

Employees

35

Key Details

Price

$0.40(-4.69%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$41.09M(+13.89% YoY)

Annual EPS

-$0.23(+39.47% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.40
EQ price is $0.40

30-Day Relative Volume

0.22
EQ 30-day relative volume is 0.22

Price Performance

Price Today change

-4.69%
EQ price is down -4.69% today

Price YTD change

-46.64%
EQ price is down -46.64% since January 1st

Price 1-year change

-76.04%
EQ price is down -76.04% year-on-year

Price 3-year change

-84.61%
EQ price is down -84.61% over the past 3 years

Price Range

Price All-time high

$27.05
EQ price is currently -98.52% below its historical high of $27.05

Price 3-year low

$0.36
EQ price is currently +11.17% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$14.29M
EQ market capitalization is $14.29 million

Market cap 3-year change

-83.96%
EQ market capitalization is down -83.96% over the past 3 years

Market cap All-time high

$469.68M
EQ market capitalization is currently -96.96% below its historical high of $469.68 million

Market cap sector rank

22.31%
EQ market capitalization is higher than 22.31% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.32%
EQ shares outstanding is up +1.32% year-on-year

Shares Outstanding 3-Year Change

+4.21%
EQ shares outstanding is up +4.21% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.88
EQ beta is 0.88

200-day SMA

$0.76
EQ price is currently -47.64% below its 200-day simple moving average

50-day SMA

$0.60
EQ price is currently -33.26% below its 50-day simple moving average

RSI

34.67
EQ 14-day relative strength index is 34.67

Volume

0.22
EQ 30-day relative volume is 0.22

ATR

$0.06
EQ average true range is $0.06

10-day Historical Volatility

62.73%
EQ 10-day historical volatility is 62.73%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$41.09M
EQ annual revenue is $41.09 million

Revenue Analysts estimate

-
EQ annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+13.89%
EQ annual revenue is up +13.89% year-on-year

Revenue Sector rank

44.66%
EQ annual revenue is higher than 44.66% of companies in Healthcare sector

EPS

EPS

-$0.23
EQ annual earnings per share is -$0.23

EPS Analysts estimate

-$0.85
EQ annual earnings per share is currently -72.94% lower than the consensus analysts' forecast

EPS 1-year change

+39.47%
EQ annual earnings per share is up +39.47% year-on-year

EPS Sector rank

75.95%
EQ annual earnings per share is higher than 75.95% of companies in Healthcare sector

Profit

Gross profit

-
EQ annual gross profit value is unknown

Gross margin

-
EQ annual gross profit margin value is unknown

Operating profit

-$8.27M
EQ annual operating income is -$8.27 million

Operating margin

-20.12%
EQ annual operating profit margin is -20.12%

Net income

-$8.07M
EQ annual net profit is -$8.07 million

Net margin

-19.63%
EQ annual net profit margin is -19.63%

Expenses

Total expenses

$49.36M
EQ annual total expenses is $49.36 million

Operating expenses

$49.36M
EQ annual total operating expenses is $49.36 million

Cost of goods sold

-
EQ annual cost of goods sold value is unknown

Selling, general & administrative expenses

$11.94M
EQ annual SGA is $11.94 million

Depreciation and amortization

$137.00K
EQ annual depreciation & amortization is $137.00 thousand

Interest expense

$0.00
EQ annual interest expense is $0.00

Income tax

$361.00K
EQ annual income tax is $361.00 thousand

EBIT & EBITDA

EBIT

-$7.71M
EQ annual earnings before interest & taxes is -$7.71 million

EBITDA

-$7.57M
EQ annual EBITDA is -$7.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$25.60M
EQ annual total assets is $25.60 million

Non current assets

$626.00K
EQ annual long term assets is $626.00 thousand

Current assets

$24.98M
EQ annual total current assets is $24.98 million

Cash and cash equivalents

$18.09M
EQ annual cash & cash equivalents is $18.09 million

Accounts receivable

$0.00
EQ annual accounts receivable is $0.00

Inventory

-
EQ annual inventory value is unknown

Liabilities

Total liabilities

$6.54M
EQ annual total liabilities is $6.54 million

Long term liabilities

$187.00K
EQ annual total long term liabilities is $187.00 thousand

Current liabilities

$6.36M
EQ annual total current liabilities is $6.36 million

Accounts payable

$2.68M
EQ annual accounts payable is $2.68 million

Debt

Total debt

$384.00K
EQ annual total debt is $384.00 thousand

Total debt 1-year change

-53.4%
EQ annual total debt is down -53.4% year-on-year

Long term debt

$187.00K
EQ annual long term debt is $187.00 thousand

Short term debt

$197.00K
EQ annual short term debt is $197.00 thousand

Equity & Capital

Shareholders equity

$19.06M
EQ annual stockholders equity is $19.06 million

Book value

$19.06M
EQ annual book value is $19.06 million

Retained earnings

-$193.81M
EQ annual retained earnings is -$193.81 million

Working capital

$18.62M
EQ annual working capital is $18.62 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$19.03M
EQ annual cash flow from operations is -$19.03 million

Cash from operations 1-year change

+12.66%
EQ annual cash flow from operations is up +12.66% year-on-year

Cash from investing

$13.81M
EQ annual cash flow from investing activities is $13.81 million

Cash from investing 1-year change

+390.09%
EQ annual cash flow from investing activities is up +390.09% year-on-year

Cash from financing

$164.00K
EQ annual cash flow from financing activities is $164.00 thousand

Cash from financing 1-year change

+101.78%
EQ annual cash flow from financing activities is up +101.78% year-on-year

CAPEX

CAPEX

$85.00K
EQ annual capital expenditures is $85.00 thousand

CAPEX 1-year change

+70%
EQ annual capital expenditures is up +70% year-on-year

Free Cash Flow

Free cash flow

-$19.11M
EQ annual free cash flow is -$19.11 million

Free cash flow 1-year change

+12.47%
EQ annual free cash flow is up +12.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
EQ annual gross profit margin value is unknown

Operating margin

-20.12%
EQ annual operating profit margin is -20.12%

Net margin

-19.63%
EQ annual net profit margin is -19.63%

ROA & ROE

ROA

-21.19%
EQ annual return on assets is -21.19%

ROE

-38.75%
EQ annual return on equity is -38.75%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EQ price to earnings ratio value is unknown

PE ratio Sector rank

-
EQ price to earnings ratio is unknown

PB Ratio

PB ratio

0.75
EQ price to book ratio is 0.75

PB ratio Sector rank

35.81%
EQ price to book ratio is higher than 35.81% of companies in Healthcare sector

PS Ratio

PS ratio

0.35
EQ price to sales ratio is 0.35

PS ratio Sector rank

10.36%
EQ price to sales ratio is higher than 10.36% of companies in Healthcare sector

Enterprise value

Enterprise value

-$3.41M
EQ enterprise value is -$3.41 million

Enterprise value Sector rank

6.9%
EQ enterprise value is higher than 6.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.45
EQ EV/EBITDA is 0.45

EV/EBITDA Sector rank

72.6%
EQ EV/EBITDA is higher than 72.6% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.93
EQ annual current ratio is 3.93

Quick ratio

-
EQ annual quick ratio value is unknown

Leverage

Debt to equity

0.00
EQ annual debt to equity ratio is 0.00

Interest coverage ratio

-
EQ annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
EQ piotroski f-score value is unknown

Altman Z-Score

-7.80
EQ altman z-score is -7.80

Analyst ratings

Recent major analysts updates

Mar 28, 25 Leerink Partners
Market Perform
Nov 1, 24 Jones Trading
Hold
Aug 19, 24 HC Wainwright & Co.
Buy
Jun 5, 24 HC Wainwright & Co.
Buy
May 17, 24 HC Wainwright & Co.
Buy
Apr 2, 24 HC Wainwright & Co.
Buy
Dec 26, 23 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy
Aug 14, 23 HC Wainwright & Co.
Buy
Aug 14, 23 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

ALUR logo
Allurion Technologies (ALUR)
PHGE logo
BiomX (PHGE)
BRTX logo
BioRestorative Therapies (BRTX)
HBIO logo
Harvard Bioscience (HBIO)
PETV logo
PetVivo Holdings (PETV)
GOVX logo
GeoVax Labs (GOVX)
MBRX logo
Moleculin Biotech (MBRX)
LFWD logo
ReWalk Robotics (LFWD)
CANF logo
Can-Fite BioPharma (CANF)
  • What is the ticker symbol for Equillium?
  • Does Equillium pay dividends?
  • What sector is Equillium in?
  • What industry is Equillium in?
  • What country is Equillium based in?
  • When did Equillium go public?
  • Is Equillium in the S&P 500?
  • Is Equillium in the NASDAQ 100?
  • Is Equillium in the Dow Jones?
  • When was Equillium's last earnings report?
  • When does Equillium report earnings?
  • Should I buy Equillium stock now?

What is the ticker symbol for Equillium?

The ticker symbol for Equillium is NASDAQ:EQ

Does Equillium pay dividends?

No, Equillium does not pay dividends

What sector is Equillium in?

Equillium is in the Healthcare sector

What industry is Equillium in?

Equillium is in the Biotechnology industry

What country is Equillium based in?

Equillium is headquartered in United States

When did Equillium go public?

Equillium's initial public offering (IPO) was on October 12, 2018

Is Equillium in the S&P 500?

No, Equillium is not included in the S&P 500 index

Is Equillium in the NASDAQ 100?

No, Equillium is not included in the NASDAQ 100 index

Is Equillium in the Dow Jones?

No, Equillium is not included in the Dow Jones index

When was Equillium's last earnings report?

Equillium's most recent earnings report was on Mar 27, 2025

When does Equillium report earnings?

The next expected earnings date for Equillium is May 9, 2025

Should I buy Equillium stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page